Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Home
R&D
Page 2
R&D
Featured posts
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AbbVie and Xilio Therapeutics to develop novel tumor-activated immunotherapies
14th February 2025
Royalty Pharma to provide $250m R&D funding in Biogen lupus collaboration
FDA orphan drug and rare pediatric disease designations granted to Arbor Biotechnologies’ primary hyperoxaluria type 1 treatment
Relmada Therapeutics acquires potential Tourette syndrome therapy from Asarina Pharma
Vanda Pharmaceuticals and AnaptysBio announce global license agreement for Generalized Pustular Psoriasis treatment
Glox Therapeutics awarded share of £3m Collaborative Discovery Programme funding from...
21st January 2025
Lyndra forms strategic clinical research and commercial manufacturing services collaboration with...
17th January 2025
AbbVie and Simcere Zaiming to develop novel trispecific antibody candidate in...
16th January 2025
Gilead and LEO Pharma to accelerate development of oral STAT6 program...
15th January 2025
Newron and Myung In Pharm announce license agreement for schizophrenia treatment...
15th January 2025
Orna Therapeutics and Vertex Pharmaceuticals to develop next generation approaches for...
10th January 2025
Antibody-drug conjugate receives US FDA Breakthrough Therapy Designation in late-line relapsed...
10th January 2025
Araris enters collaboration with Chugai to develop next-generation ADCs
10th January 2025
Candid Therapeutics enters agreement with WuXi Biologics on trispecific T-cell Engager
9th January 2025
Innovent Biologics and Roche to advance antibody drug conjugate candidate in...
7th January 2025
1
2
3
...
53
Page 2 of 53
News
AbbVie and Xilio Therapeutics to develop novel tumor-activated immunotherapies
14th February 2025
AbbVie and Xilio Therapeutics, a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, have announced a collaboration and...
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
14th February 2025
The Duchenne muscular dystrophy (DMD) market across the seven major markets (7MM*) is set to grow from $2.3 billion in 2023 to $5.2 billion...
Royalty Pharma to provide $250m R&D funding in Biogen lupus collaboration
13th February 2025
Royalty Pharma has entered into an agreement with Biogen to provide research and development (R&D) funding of up to $250 million for litifilimab, a...